Overview
Eosinophilic Esophagitis (EoE) Essentials for the Multidisciplinary Provider Team
Learning Hub
Click the "Start Activity" button to indicate you have reviewed the CME/CE information for this activity.
Start ActivityCME/CE is no longer available for this activity
The current standard of care for patients with EoE is suboptimal and often achieves only limited relief of symptoms. However, an approved therapy is now available and novel therapeutic options continue to be evaluated as management of this disease evolves rapidly. This self-paced, interactive education includes a personalized learning assessment that is designed to sharpen your knowledge and competency in EoE care, as well as a robust content repository from which your personalized curriculum will be drawn across the spectrum of EoE care. This unique 2-part activity accommodates the diverse learning needs of the multidisciplinary provider team to ensure consistent knowledge across clinician types to support optimal EoE care for all patients. Put your knowledge to the test and see how you stack up relative to your fellow clinicians and create your own customized learning experience!
This activity is intended for physicians, nurses, nurse practitioners, and physician assistants who treat EoE in the allergy/immunology or gastroenterology settings.
The current standard of care for patients with EoE is suboptimal and often achieves only limited relief of symptoms. However, an approved therapy is now available and novel therapeutic options continue to be evaluated as management of this disease evolves rapidly. This self-paced, interactive education includes a personalized learning assessment that is designed to sharpen your knowledge and competency in EoE care, as well as a robust content repository from which your personalized curriculum will be drawn across the spectrum of EoE care. This unique 2-part activity accommodates the diverse learning needs of the multidisciplinary provider team to ensure consistent knowledge across clinician types to support optimal EoE care for all patients. Put your knowledge to the test and see how you stack up relative to your fellow clinicians and create your own customized learning experience!
Upon completion of this activity, participants will be able to:
• Select and incorporate strategies to facilitate coordinated interdisciplinary EoE care among gastroenterologists, allergists, and nutritionists.
• Outline the latest recommendations and criteria for diagnosing EoE.
• Discuss the chronic nature of EoE and importance of maintenance therapy.
• Identify and optimize introduction of novel treatments into EoE management plans.
• Interpret safety and efficacy data with therapies under investigation for EoE.
• Select and incorporate strategies to facilitate coordinated interdisciplinary EoE care among gastroenterologists, allergists, and nutritionists.
• Outline the latest recommendations and criteria for diagnosing EoE.
• Discuss the chronic nature of EoE and importance of maintenance therapy.
• Identify and optimize introduction of novel treatments into EoE management plans.
• Interpret safety and efficacy data with therapies under investigation for EoE.
EoE Epidemiology and Burden
• Definition, incidence and prevalence, risk factors, disease burden for patients and families
EoE Pathophysiology and Disease Course
• Pathophysiology, disease persistence, consequences of undiagnosed EoE, long-term clinical outcomes, symptom recurrence and need for maintenance therapy
EoE Diagnosis
• Signs and symptoms, clinical presentation, comorbidities, diagnostic algorithm and criteria, emerging non-invasive diagnostic tools and biomarkers, complexities in diagnosis
Current and Evolving Treatment Approaches
• Treatment algorithm, dietary interventions, esophageal dilation, proton pump inhibitors, corticosteroids, dupilumab, emerging therapies
Multidisciplinary Care Coordination
• Multidisciplinary EoE team and their roles, workflows, benefits of multidisciplinary care, transition from pediatric to adult care
EoE Patient Cases
• Pediatric patient case, adult patient case
• Definition, incidence and prevalence, risk factors, disease burden for patients and families
EoE Pathophysiology and Disease Course
• Pathophysiology, disease persistence, consequences of undiagnosed EoE, long-term clinical outcomes, symptom recurrence and need for maintenance therapy
EoE Diagnosis
• Signs and symptoms, clinical presentation, comorbidities, diagnostic algorithm and criteria, emerging non-invasive diagnostic tools and biomarkers, complexities in diagnosis
Current and Evolving Treatment Approaches
• Treatment algorithm, dietary interventions, esophageal dilation, proton pump inhibitors, corticosteroids, dupilumab, emerging therapies
Multidisciplinary Care Coordination
• Multidisciplinary EoE team and their roles, workflows, benefits of multidisciplinary care, transition from pediatric to adult care
EoE Patient Cases
• Pediatric patient case, adult patient case
This activity is sponsored by the Academy for Continued Healthcare Learning (ACHL) and Purdue University College of Pharmacy.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
Evidence shows that patients with eosinophilic esophagitis (EoE) managed in a multidisciplinary clinic have better outcomes. This self-paced, 2-part educational activity allows you to create your own customized learning experience through an interactive learning assessment that leads to personalized education recommendations and resources from a robust content repository.
Do you specialize in gastroenterology? Enhance your knowledge of EoE risk factors, common symptoms, and how symptoms change over time; update your understanding of diagnostic criteria; hear expert recommendations for endoscopic procedures; and learn about current and emerging therapeutic options and considerations underlying treatment selection.
Is your focus or interest allergy/immunology? Learn how to better identify EoE risk factors, common symptoms, and how symptoms change over time; update your understanding of diagnostic criteria; and learn about the underlying inflammatory pathophysiology and how it has driven the development of new treatments.
Dieticians, you can enhance your knowledge of elimination diets for EoE; apply strategies for elimination diets in shared decision making with patients; and hear expert recommendations for dietary and nutritional strategies to help patients adhere to elimination diets. Regardless of your area of expertise, you will find out how to incorporate multidisciplinary care in your practice for the long-term treatment and monitoring of your patients with EoE.
Whether you’re a physician, NP/PA, nurse, dietitian, or other clinician, you’ll have the framework and tools you need to help your patients manage this difficult-to-treat condition. Don’t delay! Access this education today!
Hear from our chair, Dr. Evan Dellon to learn more about the goals and topics of this unique activity.
How can this activity help you? Hear from our expert faculty!
Do you specialize in gastroenterology? Enhance your knowledge of EoE risk factors, common symptoms, and how symptoms change over time; update your understanding of diagnostic criteria; hear expert recommendations for endoscopic procedures; and learn about current and emerging therapeutic options and considerations underlying treatment selection.
Is your focus or interest allergy/immunology? Learn how to better identify EoE risk factors, common symptoms, and how symptoms change over time; update your understanding of diagnostic criteria; and learn about the underlying inflammatory pathophysiology and how it has driven the development of new treatments.
Dieticians, you can enhance your knowledge of elimination diets for EoE; apply strategies for elimination diets in shared decision making with patients; and hear expert recommendations for dietary and nutritional strategies to help patients adhere to elimination diets. Regardless of your area of expertise, you will find out how to incorporate multidisciplinary care in your practice for the long-term treatment and monitoring of your patients with EoE.
Whether you’re a physician, NP/PA, nurse, dietitian, or other clinician, you’ll have the framework and tools you need to help your patients manage this difficult-to-treat condition. Don’t delay! Access this education today!
Hear from our chair, Dr. Evan Dellon to learn more about the goals and topics of this unique activity.
How can this activity help you? Hear from our expert faculty!
Evan Dellon, MD, MPH (Chair)
Department of Medicine
Division of Gastroenterology and Hepatology
Adjunct Professor of Epidemiology
Director, CGIBD Biostatistics and Clinical Research Core
Director, Center for Esophageal Diseases and Swallowing
School of Medicine, University of North Carolina at Chapel Hill
Chapel Hill, NC
Department of Medicine
Division of Gastroenterology and Hepatology
Adjunct Professor of Epidemiology
Director, CGIBD Biostatistics and Clinical Research Core
Director, Center for Esophageal Diseases and Swallowing
School of Medicine, University of North Carolina at Chapel Hill
Chapel Hill, NC
Katherine Alexander, MHS, PA-C
Physician Assistant
Division of Gastroenterology
Hospital of the University of Pennsylvania
Philadelphia, PA
Bethany Doerfler, MS, RDN
Adjunct Faculty
Senior Clinical Research Dietitian
Division of Gastroenterology & Hepatology
Northwestern University Feinberg School of Medicine
Chicago, IL
Emily Clarke McGowan, MD, PhD
Associate Professor
Department of Internal Medicine and Pediatrics
Allergy & Clinical Immunology
University of Virginia
Charlottesville, VA
Liza Hillel, MSN, CRNP (Planning Committee/Reviewer)
Clinical Coordinator
Advanced Practice Providers Lead
Division of Gastroenterology and Hepatology
University of Pennsylvania
Philadelphia, PA
To ensure compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Purdue University requires that all individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflicts of interest identified are thoroughly assessed by Purdue University to ensure fair balance, scientific rigor, and accepted patient care recommendations of the educational activity. (Disclosures listed here)
All relevant conflicts of interest have been mitigated prior to the start of the activity.
Purdue University College of Pharmacy requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
The following financial relationships have been provided:
Evan Dellon, MD, MPH, (Chair)
Sources of Funding for Research: Adare/Ellodi, Allakos, Arena, AstraZeneca, GlaxoSmithKline, Meritage, Miraca, Nutricia, Celgene/Receptos/Bristol Myers Squibb, Regeneron Pharmaceuticals, Inc., Revolo, Shire/Takeda
Consultant: Abbott, Abbvie, Adare/ Ellodi, Aimmune, Akesobio, ALK, Allakos, Alphasigma, Amgen, Arena, Aslan, AstraZeneca, Avir, Biorasi, Calypso, Celgene/Receptos/Bristol Myers Squibb, Celldex, Eli Lilly, EsoCap, Eupraxia, Ferring, GlaxoSmithKline, Gossamer Bio, Invea, Landos, LucidDx, Morphic, Nextstone Immunology, Nutricia, Parexel/Calyx, Phathom, Regeneron Pharmaceuticals, Inc., Revolo, Robarts/Alimentiv, Salix, Sanofi, Shire/Takeda, Target RWE, Upstream Bio
Educational grant: Allakos, Banner, Holoclara
Emily Clarke McGowan, MD, PhD, (Faculty)
Research Support (Site PI for TREET Study): Regeneron Pharmaceuticals, Inc.
The following faculty have no financial relationships:
Katherine Alexander, MHS, PA-C, (Faculty)
Bethany Doerfler, MS, RDN, (Faculty)
Liza Hillel, MSN, CRNP, (Faculty)
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Proton pump inhibitors, budesonide, fluticasone, cendakimab (RPC4046), QAX576, mepolizumab, reslizumab, benralizumab, lirentelimab (AK002), etrasimod, and IRL201104 are not approved for the treatment of EoE
None of the planners, reviewers, Academy for Continued Healthcare Learning staff, and Purdue University College of Pharmacy staff have relevant financial relationship(s) with ineligible companies to disclose unless listed below.
The content for this activity was developed independently of the ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
Completion of all modules are expected to take up to 3.5 hours to complete. To receive credit, participants are required to complete the formative assessment, view the customized education, and complete the posttest and evaluation. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Michelle Forcier at mforcier@achlcme.org.
Purdue University College of Pharmacy is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Purdue University College of Pharmacy designates this enduring material for a maximum of 3.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC
Purdue University Continuing Nursing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This program is approved for 3.5 contact hours.
This activity is approved for 3.5 contact hour(s) of continuing education (which includes 0.75 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 22105835. This activity was planned in accordance with AANP Accreditation Standards and Policies.
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 3.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 10/31/2022 to 10/31/2023. AAPA reference number: CME-208074.
